Enhabit Home Health & Hospice Announces Date of 2024 Second Quarter Earnings Call
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference
Enhabit Reiterates That Its Current Board Is Best Positioned to Deliver Enhanced Value in Letter to Stockholders
Sector Update: Health Care Stocks Advance in Afternoon Trading
Health care stocks were rising Friday afternoon, with the NYSE Health Care Index adding 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.4%. The iShares Biotechnology ETF (IBB) gained 0.4%.
Sector Update: Health Care
Health care stocks were rising Friday afternoon, with the NYSE Health Care Index adding 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.4%. The iShares Biotechnology ETF (IBB) advanced 0.4
Enhabit Board Faces Proxy Fight From Shareholder AREX Capital
Enhabit's (EHAB) board faces a proxy fight from shareholder AREX Capital Management, which said Friday in a letter to investors that the home health-care provider's strategies "are not working." "Enha
Express News | Enhabit Shareholder AREX Capital Management Issues Letter Expressing 'Disappointment in Enhabit's Continued Excuses and Empty Promises'
Enhabit Releases Investor Presentation Demonstrating Execution of Clear Growth Strategy and Path to Unlock Shareholder Value
Recent Results Demonstrate Improving Performance Despite Headwinds Board Has Taken Decisive Actions in Light of the Challenges Faced by Enhabit Since the Spin Enhabit's Proposed Board is Specifically Designed to
Enhabit Is Maintained at Underperform by B of A Securities
Enhabit Is Maintained at Underperform by B of A Securities
Enhabit Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/27/2024 -1.84% B of A Securities $9 → $8 Maintains Underperform 05/14/2024 4.29% Leerink Partners → $8.
BofA Securities Maintains Enhabit(EHAB.US) With Sell Rating, Cuts Target Price to $8
BofA Securities analyst Joanna Gajuk maintains $Enhabit(EHAB.US)$ with a sell rating, and adjusts the target price from $9 to $8.According to TipRanks data, the analyst has a success rate of 58.6% and
Express News | Enhabit Inc: Recommends Stockholders Vote for Enhabit's Director Nominees on Yellow Proxy Card
Enhabit Demonstrates Progress to Stabilize Business and Position Company for Profitable Growth
Addresses Misleading Claims Made by AREX AREX's Attempt to Take Control of Enhabit's Board Threatens Stabilization of Business Recommends Stockholders Vote FOR Enhabit's Director Nominees on the YELLOW Proxy
Enhabit's (NYSE:EHAB) Returns On Capital Tell Us There Is Reason To Feel Uneasy
AREX Capital Sets the Record Straight Regarding Enhabit's Misleading Assertions
AREX Capital Management, LP (together with its affiliates, "AREX" or "we"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) ("Enhabit"), today issued an open letter to its fellow stockholders regarding the misleading statements in Enhabit's recent communications.
Enhabit Home Health & Hospice Named in U.S. News & World Report's 2024-2025 Best Companies to Work For
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it was named as one of U.S. News & World Report's 2024-2025 Best Companies to Work For in the South. The U.S. News
Enhabit Says Board, Management Team Taking Necessary Steps to Evolve Into a Stronger, More Resilient Post-Spin-Off Public Company
Enhabit Says Board, Management Team Taking Necessary Steps to Evolve Into a Stronger, More Resilient Post-Spin-Off Public Company
Express News | NYSE Order Imbalance 100351.0 Shares on Sell Side
Express News | Arex Capital Management - Beneficial Owners of About 2.4 Mln Shares of Enhabit, Representing About 4.9% of Common Shares Outstanding
Express News | Arex Capital Management - Reaffirms View of Substantial Unrecognized Value of Enhabit
Express News | Arex Capital Management - Expresses Disappointment That Enhabit’s Board Has Chosen Not to Engage